<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="sv">
	<id>https://referensmetodik.folkhalsomyndigheten.se/index.php?action=history&amp;feed=atom&amp;title=Referenser_kopplade_till_%C3%96LI-epidemiologi</id>
	<title>Referenser kopplade till ÖLI-epidemiologi - Versionshistorik</title>
	<link rel="self" type="application/atom+xml" href="https://referensmetodik.folkhalsomyndigheten.se/index.php?action=history&amp;feed=atom&amp;title=Referenser_kopplade_till_%C3%96LI-epidemiologi"/>
	<link rel="alternate" type="text/html" href="https://referensmetodik.folkhalsomyndigheten.se/index.php?title=Referenser_kopplade_till_%C3%96LI-epidemiologi&amp;action=history"/>
	<updated>2026-05-14T07:00:57Z</updated>
	<subtitle>Versionshistorik för denna sida på wikin</subtitle>
	<generator>MediaWiki 1.35.8</generator>
	<entry>
		<id>https://referensmetodik.folkhalsomyndigheten.se/index.php?title=Referenser_kopplade_till_%C3%96LI-epidemiologi&amp;diff=6205&amp;oldid=prev</id>
		<title>Magnus Thore den 12 februari 2010 kl. 11.55</title>
		<link rel="alternate" type="text/html" href="https://referensmetodik.folkhalsomyndigheten.se/index.php?title=Referenser_kopplade_till_%C3%96LI-epidemiologi&amp;diff=6205&amp;oldid=prev"/>
		<updated>2010-02-12T11:55:13Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left diff-editfont-monospace&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;sv&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Äldre version&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Versionen från 12 februari 2010 kl. 11.55&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot; &gt;Rad 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Rad 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&#039;diff-marker&#039;&gt;−&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;Till innehållsförteckningen för [[Referensmetodik:Övre luftvägsinfektioner (ÖLI)]]&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;td class=&#039;diff-marker&#039;&gt;+&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;Till innehållsförteckningen för [[Referensmetodik: Övre luftvägsinfektioner (ÖLI)]]&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;----&lt;/div&gt;&lt;/td&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;----&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l8&quot; &gt;Rad 8:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Rad 8:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*2.	Ingvarsson L. Acute otitis media in children. Doktorsavhandling, Lund 1982.&lt;/div&gt;&lt;/td&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*2.	Ingvarsson L. Acute otitis media in children. Doktorsavhandling, Lund 1982.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&#039;diff-marker&#039;&gt;−&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*3.	Konsensusuttalande - Barn med &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;öroninflamniationer&lt;/del&gt;. MFR/&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Spti &lt;/del&gt;1991. Spri tryck 208. ISON 91-7926-071-3.&lt;/div&gt;&lt;/td&gt;&lt;td class=&#039;diff-marker&#039;&gt;+&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*3.	Konsensusuttalande - Barn med &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;öroninflammationer&lt;/ins&gt;. MFR/&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Spri &lt;/ins&gt;1991. Spri tryck 208. ISON 91-7926-071-3.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*4.	Strömberg A, Romanus V, Burman LG. Outbreak of group A streptococcal bacteremia in Sweden: An epidemiologic and clinical study. J Infect Dis 1991;164:595-598.&lt;/div&gt;&lt;/td&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*4.	Strömberg A, Romanus V, Burman LG. Outbreak of group A streptococcal bacteremia in Sweden: An epidemiologic and clinical study. J Infect Dis 1991;164:595-598.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l26&quot; &gt;Rad 26:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Rad 26:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*11.	Linglöf T. Difteri - ett hot från Öst? Läkartidningen, 1994;91:363-365.&lt;/div&gt;&lt;/td&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*11.	Linglöf T. Difteri - ett hot från Öst? Läkartidningen, 1994;91:363-365.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&#039;diff-marker&#039;&gt;−&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*12.	Olsson-Liljequist B, Burman LG, Kallings I and the Swedish &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Retpiratoty &lt;/del&gt;Tract Study Group. Antibiotic susceptibility of upper respiratory tract pathogens in Sweden: A seven year follow-up study including loracarbef. Scand J Infect Dis 1992;24:485-493.&lt;/div&gt;&lt;/td&gt;&lt;td class=&#039;diff-marker&#039;&gt;+&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*12.	Olsson-Liljequist B, Burman LG, Kallings I and the Swedish &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Respiratoty &lt;/ins&gt;Tract Study Group. Antibiotic susceptibility of upper respiratory tract pathogens in Sweden: A seven year follow-up study including loracarbef. Scand J Infect Dis 1992;24:485-493.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*13.	Holmström L, Nyman B, Rosengren M, Wallander S, Ripa T. Outbreaks of infections with erythromycin-resistant group A streptococci in child day care centers- Scand J Infect Dis 1990;22:179-185.&lt;/div&gt;&lt;/td&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*13.	Holmström L, Nyman B, Rosengren M, Wallander S, Ripa T. Outbreaks of infections with erythromycin-resistant group A streptococci in child day care centers- Scand J Infect Dis 1990;22:179-185.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&#039;diff-marker&#039;&gt;−&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*14.	Seppäla H et al. Resistance to &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;erythronycin &lt;/del&gt;in group A streptocccci. The New Engl J Med 1992;326:292-297.&lt;/div&gt;&lt;/td&gt;&lt;td class=&#039;diff-marker&#039;&gt;+&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*14.	Seppäla H et al. Resistance to &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;erythromycin &lt;/ins&gt;in group A streptocccci. The New Engl J Med 1992;326:292-297.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*15.	Ekdahl K, Kamme C. Increasing resistance to penicillin in &amp;#039;&amp;#039;Streptococcus pneumoniae&amp;#039;&amp;#039; in southern Sweden. Scand J Infect Dis 1994;26:301-304.&lt;/div&gt;&lt;/td&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*15.	Ekdahl K, Kamme C. Increasing resistance to penicillin in &amp;#039;&amp;#039;Streptococcus pneumoniae&amp;#039;&amp;#039; in southern Sweden. Scand J Infect Dis 1994;26:301-304.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l36&quot; &gt;Rad 36:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Rad 36:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*16.	Forsgren A, Walder M. Antimicrobial susceptibility of bacterial isolates in south Sweden including a 13-year follow-up study of some respiratory tract pathogens. APMIS 1994;102:227-235.&lt;/div&gt;&lt;/td&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*16.	Forsgren A, Walder M. Antimicrobial susceptibility of bacterial isolates in south Sweden including a 13-year follow-up study of some respiratory tract pathogens. APMIS 1994;102:227-235.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class=&#039;diff-marker&#039;&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&#039;diff-marker&#039;&gt;−&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*17.	Soares S, Kristinsson KG, Musser JM, Tomsasz A. Evidence for the introduction of a multiresistant clone of serotype 6B &amp;#039;&amp;#039;Streptococcus pneumoniae&amp;#039;&amp;#039; from Spain to &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Icetand &lt;/del&gt;in the late 1980s. J Infect Dis 1993;168:158-163&lt;/div&gt;&lt;/td&gt;&lt;td class=&#039;diff-marker&#039;&gt;+&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*17.	Soares S, Kristinsson KG, Musser JM, Tomsasz A. Evidence for the introduction of a multiresistant clone of serotype 6B &amp;#039;&amp;#039;Streptococcus pneumoniae&amp;#039;&amp;#039; from Spain to &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Iceland &lt;/ins&gt;in the late 1980s. J Infect Dis 1993;168:158-163&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt; &lt;/td&gt;&lt;td class=&#039;diff-marker&#039;&gt;+&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt; &lt;/td&gt;&lt;td class=&#039;diff-marker&#039;&gt;+&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;[[Kategori:ÖLI]]&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt; &lt;/td&gt;&lt;td class=&#039;diff-marker&#039;&gt;+&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;[[Kategori:Epidemiologi]]&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt; &lt;/td&gt;&lt;td class=&#039;diff-marker&#039;&gt;+&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;[[Kategori:Smittskyddslagens sjukdomar]]&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Magnus Thore</name></author>
	</entry>
	<entry>
		<id>https://referensmetodik.folkhalsomyndigheten.se/index.php?title=Referenser_kopplade_till_%C3%96LI-epidemiologi&amp;diff=6204&amp;oldid=prev</id>
		<title>Magnus Thore: Skapade sidan med &#039;&#039;&#039;Till innehållsförteckningen för Referensmetodik:Övre luftvägsinfektioner (ÖLI)&#039;&#039; ----  == REFERENSER ==  *1.	Smedby B, Korpela M. Diagnosredovisning för läkarbesök…&#039;</title>
		<link rel="alternate" type="text/html" href="https://referensmetodik.folkhalsomyndigheten.se/index.php?title=Referenser_kopplade_till_%C3%96LI-epidemiologi&amp;diff=6204&amp;oldid=prev"/>
		<updated>2010-02-12T11:51:34Z</updated>

		<summary type="html">&lt;p&gt;Skapade sidan med &amp;#039;&amp;#039;&amp;#039;Till innehållsförteckningen för &lt;a href=&quot;/index.php?title=Referensmetodik:%C3%96vre_luftv%C3%A4gsinfektioner_(%C3%96LI)&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;Referensmetodik:Övre luftvägsinfektioner (ÖLI) (sidan existerar inte)&quot;&gt;Referensmetodik:Övre luftvägsinfektioner (ÖLI)&lt;/a&gt;&amp;#039;&amp;#039; ----  == REFERENSER ==  *1.	Smedby B, Korpela M. Diagnosredovisning för läkarbesök…&amp;#039;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Ny sida&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;#039;&amp;#039;Till innehållsförteckningen för [[Referensmetodik:Övre luftvägsinfektioner (ÖLI)]]&amp;#039;&amp;#039;&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
== REFERENSER ==&lt;br /&gt;
&lt;br /&gt;
*1.	Smedby B, Korpela M. Diagnosredovisning för läkarbesök år 1991 vid vårdcentralen 1 Tierp. Uppsala Universitet, Enheten för forskning inom primärvård och socialtjänst. 1992-06-01.&lt;br /&gt;
&lt;br /&gt;
*2.	Ingvarsson L. Acute otitis media in children. Doktorsavhandling, Lund 1982.&lt;br /&gt;
&lt;br /&gt;
*3.	Konsensusuttalande - Barn med öroninflamniationer. MFR/Spti 1991. Spri tryck 208. ISON 91-7926-071-3.&lt;br /&gt;
&lt;br /&gt;
*4.	Strömberg A, Romanus V, Burman LG. Outbreak of group A streptococcal bacteremia in Sweden: An epidemiologic and clinical study. J Infect Dis 1991;164:595-598.&lt;br /&gt;
 &lt;br /&gt;
*5.	Holm SE, Norrby A, Bergholm AM, Norgren M. Aspects of pathogenesis of serious group A Streptococcal infections in Sweden 1988-1989. J Infect Dis 1992;166:31-37.&lt;br /&gt;
&lt;br /&gt;
*6.	Martin PR., Höiby EA. Streptococcal serogroup A epidemic in Norway 1987-1988. Scand J Infect Dis 1990;22:42l-429.&lt;br /&gt;
&lt;br /&gt;
*7.	Svensson N, Holm S. Invasiva Grupp A streptokockinfektioner. epidAKTUELLT 1994:17:6.&lt;br /&gt;
&lt;br /&gt;
*8.	Eskola J, Peltola H, Käyhty H, Talaka AK, Mäkelä PH. Finnish efficacy trials with &amp;#039;&amp;#039;Haemophilus influenzae&amp;#039;&amp;#039; type b vaccines. J Infect Dis 1992;165: Suppl 1:137-138.&lt;br /&gt;
&lt;br /&gt;
*9.	Eskola J, Takala AK, Käyhty H, Peltola H, Mäkelä PH. Experience in Finland with &amp;#039;&amp;#039;Haemophilus influenzae&amp;#039;&amp;#039; type b vaccines. Vaccine, 1991;June 9:Suppl:l4-16, discussion s25.&lt;br /&gt;
&lt;br /&gt;
*10.	Christenson B, Lundbergh P. Infektionsläget allvarligt i fd Sovjet. Läkartidningen 1994;91:365-371.&lt;br /&gt;
&lt;br /&gt;
*11.	Linglöf T. Difteri - ett hot från Öst? Läkartidningen, 1994;91:363-365.&lt;br /&gt;
&lt;br /&gt;
*12.	Olsson-Liljequist B, Burman LG, Kallings I and the Swedish Retpiratoty Tract Study Group. Antibiotic susceptibility of upper respiratory tract pathogens in Sweden: A seven year follow-up study including loracarbef. Scand J Infect Dis 1992;24:485-493.&lt;br /&gt;
&lt;br /&gt;
*13.	Holmström L, Nyman B, Rosengren M, Wallander S, Ripa T. Outbreaks of infections with erythromycin-resistant group A streptococci in child day care centers- Scand J Infect Dis 1990;22:179-185.&lt;br /&gt;
&lt;br /&gt;
*14.	Seppäla H et al. Resistance to erythronycin in group A streptocccci. The New Engl J Med 1992;326:292-297.&lt;br /&gt;
&lt;br /&gt;
*15.	Ekdahl K, Kamme C. Increasing resistance to penicillin in &amp;#039;&amp;#039;Streptococcus pneumoniae&amp;#039;&amp;#039; in southern Sweden. Scand J Infect Dis 1994;26:301-304.&lt;br /&gt;
&lt;br /&gt;
*16.	Forsgren A, Walder M. Antimicrobial susceptibility of bacterial isolates in south Sweden including a 13-year follow-up study of some respiratory tract pathogens. APMIS 1994;102:227-235.&lt;br /&gt;
&lt;br /&gt;
*17.	Soares S, Kristinsson KG, Musser JM, Tomsasz A. Evidence for the introduction of a multiresistant clone of serotype 6B &amp;#039;&amp;#039;Streptococcus pneumoniae&amp;#039;&amp;#039; from Spain to Icetand in the late 1980s. J Infect Dis 1993;168:158-163&lt;/div&gt;</summary>
		<author><name>Magnus Thore</name></author>
	</entry>
</feed>